Bristol-Myers Squibb Co.

Y! CELG MM R&D deep dive BMY Roulette CELG legacy IV board (still active) CELG legacy IV board (premium) BMY Roulette 2020 @bmsnews (Company Twitter Account)

BMY / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
4300	Re: Anokion Announces Expansion of Exclusive Collaboration with Bristol Myers Squibb to Develop Novel Treatments for Autoimmune Diseases	GN	Biotech2050		0	9/24/2020 7:15:36 AM

4299	Thanks JB - EOM.	GN	Doolen		6	9/24/2020 7:11:24 AM

4298	Anokion Announces Expansion of Exclusive Collaboration with Bristol Myers Squibb to Develop Novel Treatments for Autoimmune Diseases	GN	jerrykrause		2	9/24/2020 5:47:58 AM

4297	Building IP: BMY Patent Application re "(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS"	GN	JBWIN		0	9/24/2020 12:53:11 AM

4296	Building IP: BMY Patent Application re "PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS"	GN	JBWIN		0	9/24/2020 12:51:48 AM

4295	Building IP: BMY Patent Application re "PYRROLIDINE GPR40 MODULATORS"	GN	JBWIN		1	9/24/2020 12:50:07 AM

4294	Building IP: BMY Patent Application re "ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS"	GN	JBWIN		2	9/24/2020 12:48:45 AM

4293	Building IP: BMY Patent Application re "A METHOD TO MONITOR PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO ADMINISTRATION OF GLUCOCORTICOIDS"	GN	JBWIN		2	9/24/2020 12:47:07 AM

4292	Building IP: Celgene Quanticel Research Patent Application re "TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS" (think CC-90011 w/early data recently at ESMO2020)	GN	JBWIN		2	9/24/2020 12:45:46 AM

4291	Building IP: CELG Patent Application re "PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE"	GN	JBWIN		1	9/24/2020 12:42:29 AM